Alk-Abello AS (AKBLF)
24.60
0.00 (0.00%)
USD |
OTCM |
Sep 18, 16:00
Alk-Abello Total Assets (Quarterly): 1.011B for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.011B |
| March 31, 2024 | 981.34M |
| December 31, 2023 | 998.62M |
| September 30, 2023 | 930.22M |
| June 30, 2023 | 942.26M |
| March 31, 2023 | 930.41M |
| December 31, 2022 | 907.90M |
| September 30, 2022 | 830.30M |
| June 30, 2022 | 871.45M |
| March 31, 2022 | 895.43M |
| December 31, 2021 | 887.54M |
| September 30, 2021 | 892.08M |
| June 30, 2021 | 892.17M |
| March 31, 2021 | 911.82M |
| December 31, 2020 | 919.48M |
| September 30, 2020 | 878.72M |
| June 30, 2020 | 857.31M |
| March 31, 2020 | 832.80M |
| December 31, 2019 | 823.82M |
| September 30, 2019 | 746.04M |
| June 30, 2019 | 780.00M |
| March 31, 2019 | 786.42M |
| December 31, 2018 | 745.27M |
| September 30, 2018 | 756.32M |
| June 30, 2018 | 767.07M |
| Date | Value |
|---|---|
| March 31, 2018 | 813.70M |
| December 31, 2017 | 798.98M |
| September 30, 2017 | 712.26M |
| June 30, 2017 | 705.16M |
| March 31, 2017 | 692.82M |
| December 31, 2016 | 682.47M |
| September 30, 2016 | 681.01M |
| June 30, 2016 | 673.29M |
| March 31, 2016 | 672.47M |
| December 31, 2015 | 622.83M |
| September 30, 2015 | 605.47M |
| June 30, 2015 | 587.64M |
| March 31, 2015 | 519.14M |
| December 31, 2014 | 558.22M |
| September 30, 2014 | 573.43M |
| June 30, 2014 | 607.03M |
| March 31, 2014 | 615.91M |
| December 31, 2013 | 604.87M |
| September 30, 2013 | 582.23M |
| June 30, 2013 | 562.98M |
| March 31, 2013 | 564.08M |
| December 31, 2012 | 584.01M |
| September 30, 2012 | 566.37M |
| June 30, 2012 | 536.72M |
| March 31, 2012 | 598.23M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
746.04M
Minimum
Sep 2019
1.011B
Maximum
Jun 2024
897.05M
Average
893.80M
Median
Total Assets (Quarterly) Benchmarks
| Genmab AS | 5.544B |
| Ascendis Pharma AS | 812.82M |
| Galecto Inc | 27.30M |
| Evaxion Biotech AS | 15.23M |
| IO Biotech Inc | 111.47M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 305.19M |
| Shareholders Equity (Quarterly) | 706.13M |
| Debt to Equity Ratio | 0.0394 |
| Current Ratio | 2.667 |
| Net Debt Paydown Yield | 0.11% |